Dalrada (DFCO) Removes Shell Company Status.
LIVE QUOTE
SAN DIEGO, Nov. 6, 2020
SAN DIEGO , Nov. 6, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), announced that it has filed Form 8-A12b with the U.S....
Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...
New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.
Early Bird Gets the Worm?
Here's...
Frontier Bio (FBIO) Bolstering it’s Warchest.
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
NEW YORK, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO)...
True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.
This is a Welcome Step in the Right Direction.
ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB:...
Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.
The 2021 Biotech Six Pack: Stocks We Expect to Double!
These are ideas #3 and #4 for the 'Biotech Six Pack' list. The first addition...
Dalrada (DFCO). Our 11th and Latest Ten Bagger.
We've actually had many more than 11 ten-baggers, as we report on companies which aren't clients. This is our 11th client we should say,...
Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.
https://youtu.be/vMIy8xWLOKI?t=3699
INSIDER HOLDINGS
POWERPOINT
LIVE CHART
Adding Citius (CTXR) $0.55 to Watch List.
Citius News Archive
MARKET BEAT
TIP RANKS
Disclaimer. Citius Pharma is a client, please see reports for disclosure and...
Dalrada (DFCO) Legal Counsel
CONTINUOUSLY UPDATED
Dalrada Financial Adds Robbe to Board of DirectorsDalrada Financial Corporation Hires Fletcher Robbe International
Dalrada Financial Adds Robbe to Board of Directors
HENDERSON, Nev., Aug....
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous...
Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?
Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found in Virtually all...
Latest article
We’re Up 360% in Six Weeks. Replimune (REPL).
That's a Gain of $604 Million, and That Ain't Bad!
Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...
GeoVax (GOVX) Conference Call and Transcript.
Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah.
Guess what we'll choose to do?
We have no...
Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.
Top Ranked Defense, Government and Enterprise Contractor
Trying to Break Over $0.06.
We are still sitting on the edge of our seat waiting for contract news,...
